
Thursday, August 29, 2024 11:59:26 AM

Recent BCDA News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2025 01:30:21 PM
- BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) • GlobeNewswire Inc. • 02/13/2025 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/12/2025 01:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2025 01:36:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2025 02:15:22 PM
- BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions • GlobeNewswire Inc. • 01/27/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 07:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 07:30:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 04:50:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:00:13 PM
- BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 12/17/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 10:04:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 01:30:21 PM
- BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure • GlobeNewswire Inc. • 12/04/2024 01:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/02/2024 10:03:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 01:00:13 PM
- BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024 • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 01:00:11 PM
- BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure • GlobeNewswire Inc. • 10/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:57:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:56:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 01:55:51 AM
FEATURED COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM